Press Releases :: Aerami Therapeutics Holdings, Inc.

Jul 23, 2020 8:00am EDT

Aerami Therapeutics to Present at the LifeSci Partners Summer Symposium

Jun 08, 2020 8:15am EDT

Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy for Patients with Pulmonary Arterial Hypertension to Their Pipeline

Feb 05, 2020 8:30am EST

Aerami Therapeutics Appoints Timm Crowder as Chief Operating Officer

Nov 11, 2019 8:00am EST

Aerami Therapeutics to Present Clinical Data on Dance 501 Inhaled Human Insulin at the 19th Diabetes Technology Meeting

Sep 25, 2019 7:30am EDT

Dance Biopharm Announces Rebranding to Aerami Therapeutics Reflecting a Broadened Strategic Focus on Inhaled Therapies for Chronic Diseases

rss_feed News RSS